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In the ventral tegmental area (VTA), α6-nAChRs express abundantly, but their location, 
function, pharmacology, and roles in cholinergic modulation of dopaminergic (DA) 
neurons remain elusive. Using a VTA neuron-adherent bouton preparation, we report that 
functional α6-nAChRs are located on GABAergic presynaptic boutons, where they 
mediate cholinergic modulation of GABA release onto DA neurons. Smoking-relevant 
concentrations of nicotine desensitize α6-nAChRs, cause a disinhibition in DA neurons 
and consequently mediate nicotine reward.  
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Dopaminergic (DA) neuronal activity in the ventral tegmental area (VTA) is thought to 
contribute to reward and drug reinforcement, including nicotine dependence1, 2. A variety of 
nicotinic acetylcholine receptor (nAChR) subunits are expressed in mammals by VTA DA 
neurons 3-5. In particular, α6 subunit expression is abundant, suggesting possible roles for 
nAChRs containing α6 subunit (α6*-nAChRs) in nicotine-induced reward and dependence 
in the VTA3-8.  Recent work has focused on α6*-nAChRs located on the VTA DA neuronal 
target area, the nucleus accumbens (NA), where α6*-nAChRs participate in nicotinic 
modulation of DA release9-11. However, the function, pharmacology, and the roles played 
in cholinergic modulation of GABA release by α6*-nAChRs in the VTA are poorly 
understood.  The objective of this study was to identify functional α6*-nAChRs in the VTA, 
evaluate their roles in cholinergic modulation of GABA release and elucidate how these 
receptors participate in nicotine reward. We hypothesize that α6*-nAChRs are present on 
GABAergic, pre-synaptic boutons contacting DA neurons and that they play important 
roles in mediating cholinergic regulation of inhibitory neurotransmission in the VTA. 
 
Initial experiments were designed to determine whether there are functional α6*-
nAChRs on presynaptic boutons. To achieve this goal, we used a neuron-adherent bouton 
preparation from the VTA. In this preparation, dissociated single DA neurons contain 
functional presynaptic boutons12, which are evident on the neuronal surface upon staining 
with FM1-43 (Fig. 1a and Supplementary Methods online). We then doubly labeled the 
bouton-containing neurons using biotinylated-α-conotoxin MII and GAD65/67, and most of 
the DA neurons exhibited positive, punctate staining for both markers (Fig. 1b), suggesting 
that there are α-conotoxin MII-sensitive nAChRs natively expressed on the adherent 
GABAergic presynaptic boutons. In electrophysiologically identified DA neurons 
(supplementary Fig. 1), spontaneous postsynaptic currents (sPSCs) were evident (Fig. 1). 
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These sPSCs were completely abolished by a GABAA receptor-selective antagonist, 
bicuculline (30 μM, Fig, 1c,f) but were not sensitive to ionotropic glutamate receptor 
antagonists, CNQX (20 μM) + D-APV (50 μM) (Fig. 1e,f), suggesting that the spontaneous 
currents were inhibitory sPSCs (sIPSCs). The sIPSCs were enhanced by 4-aminopyridine 
(4AP, 200 μM, Fig.1d,f), consistent with the currents resulting from neurotransmitter 
release from the presynaptic boutons. 
Fig. 1 near here 
 
Next, we asked whether these presynaptic α6*-nAChRs mediate cholinergic 
modulation of GABA release in the VTA. To address this question, we tested the effects of 
relatively selective antagonists (α-conotoxin MII or α-conotoxin P1A) for α6*-nAChRs on 
ACh-induced enhancement of GABA release (monitored by changes in sIPSC frequency). 
Figure 2a (top trace) showed that 1 mM ACh strongly enhanced the frequency but not 
amplitude of sIPSCs, suggesting that ACh increased presynaptic GABA release in bouton-
adherent VTA DA neurons. Pretreatment with 1 nM α-conotoxin P1A (or α-conotoxin MII) 
for 4 min abolished the ACh-induced increase of sIPSCs (Fig. 2a, middle trace; ACh co-
applied with α-conotoxin P1A). After a 20-min washout, the inhibitory effects of α-
conotoxin P1A were reversed (Fig. 2a, bottom trace). These results suggest that functional 
α6*-nAChRs mediate an increase of ACh-induced GABA release onto DA neurons in the 
VTA (Fig. 1b,c).  In these α-conotoxin-sensitive neurons, α4β2-nAChR antagonist (1 μM 
DHβE) or α7-nAChR antagonist (10 nM MLA) failed to prevent ACh-induced increase of 
sIPSCs under the same pretreatment conditions (supplementary Fig. 2). Interestingly, 
acute exposure to a smoking-relevant concentration of nicotine (500 nM) failed to increase 
sIPSCs in 30 neurons tested (Fig. 2d-f). However, this nicotine exposure (500 nM for 4 
min) abolished ACh-induced increases of sIPSCs (Fig. 2g-i), suggesting that smoking-
 5
relevant levels of nicotine desensitize rather than activate presynaptic α6*-nAChRs and 
eliminate cholinergic enhancement of GABA release. Chronic exposure to nicotine (0.5 
mg/kg/day i.p.) for 10 days also eliminated ACh-induced increase of sIPSCs (recorded at 
the day 11) (Fig. 2i). 
Fig. 2 near here 
The novel and important finding in the present study is that functional α6-nAChRs are 
natively expressed on GABAergic presynaptic boutons where they mediate cholinergic 
modulation of GABA release onto DA neurons in the VTA. Smoking-relevant 
concentrations of nicotine desensitize rather than activate these presynaptic α6-nAChRs 
and eliminate cholinergic enhancement of GABA release. The nicotine-induced reduction 
in GABA release will thus increase of DA neuronal activity in the VTA, driving the reward 
pathway.  
Using a fresh neuron-adherent bouton preparation, we have identified functional α6-
nAChRs on GABAergic presynaptic boutons. First, double-labeled DA neurons showed 
positive reactions to both biotinylated-α-conotoxin MII and GAD65/67, and importantly, 
both positive reaction dots were co-localized on the surface of labeled neuron, suggesting 
the α-conotoxin MII-sensitive receptors (α6-nAChRs) likely localize to the GABAergic 
boutons. This was further confirmed by pharmacological experiments, in which the block of 
voltage-gated Na+ channels (300 nM TTX) did not affect either sIPSCs or ACh-induced 
increase of sIPSCs (supplementary Fig. 3). We also examined whether ACh-induced Ca2+ 
entry into purified presynaptic boutons (VTA synaptosomes) was sensitive to α-conotoxin 
P1A, and found that 1 nM α-conotoxin P1A eliminated ACh-induced Ca2+ entry 
(supplementary Fig. 4), confirming the presence of functional α6 nAChRs on presynaptic 
boutons in the VTA. Although we cannot distinguish between GABAergic and 
glutamatergic boutons in the preparation of VTA synaptosomes, our data suggest the α-
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conotoxin P1A-sensitive portion of ACh-induced intracellular Ca2+ elevation is likely 
mediated through GABAergic boutons as it is well know that the presynaptic glutamatergic 
terminals/boutons express α7 type nAChRs13, 14. In addition, pharmacological experiments 
demonstrated that relatively selective α6*-nAChR antagonist (1 nM  α-conotoxin MII or 
P1A) abolished ACh-induced increase of sIPSC frequency but not amplitude, suggesting 
that presynaptic α6-nAChRs mediated the ACh-induced increase in GABA release.  
To determine whether α6 and β2 nAChR subunits are assembled together to form 
presynaptic α6-nAChRs, we examined ACh-induced increase of sIPSCs using β2 subunit 
knockout (KO) mice and found that the ACh-induced increase of sIPSCs was not detected 
(supplementary Fig. 5), suggesting that at least the β2 subunit is involved in the formation 
of functional presynaptic α6*-nAChRs. Considering that the nAChR β2 subunit plays a 
critical role in nicotine self-administration15, our data suggest the importance of these 
presynaptic α6β2*-nAChRs in the VTA in nicotine reward and addiction.  
Smoking-relevant concentrations of nicotine increase VTA DA neuron firing and DA 
release to its targets, namely NA and prefrontal cortex; and induce reward through 
complex mechanisms1, 13. Emerging lines of evidence have indicated that nicotine 
activates α7-nAChRs located on glutamatergic presynaptic terminals to increase 
glutamate release and/or desensitizes α4β2-nAChRs located on GABAergic neuronal 
soma to reduce the tonic input from brain stem cholinergic nuclei.  This modulation of α7- 
and α4β2-nAChRs by nicotine  increases DA neuronal activity and DA release2, 14.  Here, 
we demonstrate an additional mechanism wherein acute or chronic exposure to smoking-
relevant concentrations of nicotine does not activate but desensitizes α6*-nAChRs located 
on presynaptic GABAergic boutons in VTA DA neurons.    
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Figure legends 
Fig. 1. Spontaneous postsynaptic currents from GABAergic presynaptic boutons on 
single DA neurons mechanically dissociated from rat VTA. FM1-43 staining showed that 
a single neuron maintained presynaptic boutons (indicated by yellow arrows) after pure 
mechanical dissociation from rat VTA (a). GAD (65/67) staining of a dissociated VTA 
neuron revealed positively stained dots on the surface of the neuron, suggesting the 
presence of GABAergic presynaptic boutons (b, left, pointed by yellow arrows), while cell 
soma was unstained, suggesting a non-GABAergic neuron. The same neuron also 
exhibited positive staining with biotinylated α-conotoxin MII labeling (b, middle). The 
surface dots of neuron were double-labeled by GAD and α-conotoxin MII as evident in 
the merged image (b, right), suggesting that there are α-conotoxin MII-sensitive nAChRs 
located on GABAergic presynaptic boutons. Similar staining results have been obtained 
in six neurons dissociated from three rats. Under whole-cell patch-clamp recording (in 
voltage-clamp mode), spontaneous postsynaptic currents (sPSCs) were observed at a 
holding potential of -60 mV, and these sPSCs were completely abolished by a GABAA 
receptor antagonist, bicuculline (BMI, c), significantly enhanced by 4-aminopyridine (4AP, 
d), but were not affected by ionotropic glutamate receptor antagonist (D-APV 50 μM + 
NBQX 20 μM, e). Fig. 1f summarizes the effects of c-e on the frequency of sIPSCs. Data 
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are means ± SEM. The traces c, d and e were recorded form different neurons. Scale 
bars: 30 μm. 
 
Fig. 2. Presynaptic α6*-nAChR–mediated cholinergic modulation of GABA release onto 
DA neurons in rat VTA. Under patch-clamp whole-cell recording (in voltage-clamp mode), 
1 mM ACh increased the frequency of sIPSCs (a, top trace). Pretreatment with the α6*-
nAChR-selective antagonist 1 nM α-CTX PIA for 4 min reversibly (a, bottom trace) 
abolished (a, middle trace) the ACh-induced increase in sIPSC frequency (b). Fig. 2c 
summarizes the α-CTXPIA- and α-CTXMII-sensitive nAChR-mediated cholinergic 
modulation of presynaptic GABA release. A smoking-relevant concentration (500 nM) of 
nicotine alone failed to increase sIPSCs (d-f), but it desensitized α6*-nAChRs and 
abolished the ACh-induced increase of sIPSCs following chronic treatment at 0.5 
mg/kg/day, i.p., for 10 days (g-i). These results suggest that α6*-nAChRs mainly 
mediate cholinergic (ACh) modulation of presynaptic GABA release onto VTA DA 
neurons, and 500 nM nicotine desensitizes rather than activates these receptors, 
resulting in a disinhibition of VTA DA neurons, which may play important roles in 
nicotine-induced DA neuron excitation and nicotine reward. 
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